Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Pembrolizumab in Combination with Gemcitabine for Patients with HER2-negative Advanced Breast Cancer: GEICAM/2015–04 (Pangea-Breast) Study

L. de la Cruz-Merino,M. Gion,J. Cruz,JL. Alonso-Romero,V. Quiroga,F. Moreno,R. Andrés,M. Santisteban,M. Ramos,E. Holgado,J. Cortés,E. López-Miranda,A. Cortés,F. Henao,N. Palazón-Carrión, L. M. Rodriguez, I. Ceballos,A. Soto,A. Puertes,M. Casas,S. Benito,M. Chiesa,S. Bezares,R. Caballero,C. Jiménez-Cortegana,V. Sánchez-Margalet,F. Rojo

BMC Cancer（2022）

Cited 4|Views34
Key words
Pembrolizumab,Chemotherapy,HER2-negative,Advanced breast cancer,TILs,PD-L1,MDSCs
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined